Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway

Abstract Background Prostate cancer (PCa) is becoming the most common malignancy in men worldwide. We investigated the effect of astragaloside IV combined with PESV on the gut microbiota and metabolite of PCa mice and the process of treating PCa. Methods Nude mice were genetically modified to develo...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Cancer
المؤلفون الرئيسيون: Xujun You, Junfeng Qiu, Qixin Li, Qing Zhang, Wen Sheng, Yiguo Cao, Wei Fu
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2024-04-01
الموضوعات:
Prostate cancer
Astragaloside IV
PESV
AGE-RAGE
الوصول للمادة أونلاين:https://doi.org/10.1186/s12885-024-12167-z

الانترنت

https://doi.org/10.1186/s12885-024-12167-z

مواد مشابهة